secwatch.observer — SEC 8-K summary
======================================

Issuer:     Oric Pharmaceuticals, Inc. (ORIC)
CIK:        0001796280
Form:       8-K
Filed at:   2022-06-21T23:59:59+00:00
Accession:  0001193125-22-176987
Event type: other
Sentiment:  neutral
Materiality: 0.05
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

ORIC shareholders elect two Class II directors and ratify KPMG as auditor
-------------------------------------------------------------------------

- Steven L. Hoerter and Angie You, Ph.D. elected as Class II directors until 2025 annual meeting.
- Hoerter received 30,420,083 for, 21,252 withheld, 3,427,848 broker non-votes.
- Angie You received 30,420,703 for, 20,632 withheld, 3,427,848 broker non-votes.
- KPMG LLP ratified as independent auditor for FY2022 with 33,863,053 for, 6,025 against, 105 abstain.
- Meeting held June 17, 2022 with 85.87% of outstanding shares represented.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1796280/000119312522176987/0001193125-22-176987-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1796280/000119312522176987/d708502d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-176987

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer